Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2008
05/15/2008US20080113415 Heat resistant thermoanaerobacterium isomerase for use in production of fructose syrup
05/15/2008US20080113408 Suppressor peptides co-administered with viricidal agents for prevention and treatment of respiratory syncytial viral infection
05/15/2008US20080113407 In vivo translation system for incorporation of sulfotyrosine into proteins; directed protein evolution
05/15/2008US20080113406 Modified bacteriocins and methods for their use
05/15/2008US20080113405 Gene-Cassette For Enhancement Of Protein Production
05/15/2008US20080113401 Cell-Based Assay for the Detection of Toxic Analytes
05/15/2008US20080113381 Hemoglobin A1c Determination Method, Enzyme to be Used therefor, and Production Method Thereof
05/15/2008US20080113379 Using bisulfite conversion and sequence amplification via polymerase chain reaction as tool for determining methylation profile of genomic segments; gene expression analysis
05/15/2008US20080113378 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113377 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113376 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113375 siRNA targeting superoxide dismutase 1 (SOD1)
05/15/2008US20080113374 siRNA targeting fructose-1,6-bisphosphatase 1 (FBP1)
05/15/2008US20080113373 siRNA targeting amyloid beta (A4) precursor protein (APP)
05/15/2008US20080113372 siRNA targeting glucagon receptor (GCGR)
05/15/2008US20080113371 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders
05/15/2008US20080113370 siRNA targeting apolipoprotein B (APOB)
05/15/2008US20080113369 Small interfering RNA sequence for use as therapeutic in treatment and prevention of diabetes, alzheimer's and cancer disorders
05/15/2008US20080113362 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
05/15/2008US20080113351 Nucleotide sequence for prevention and treatment of cell proliferative disorders; antitumor agents
05/15/2008US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic
05/15/2008US20080113335 Novel Hiv-Based Recombinant Viral Clones and Use Thereof in Analytical Methods
05/15/2008US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances
05/15/2008US20080112977 Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use Thereof
05/15/2008US20080112973 Chimeric papillomavirus-like particles
05/15/2008US20080112971 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses;
05/15/2008US20080112957 Composition comprising immunoglobulin specific to epidermal growth factor receptor for treatment of cell proliferative disorders
05/15/2008US20080112951 Oligo/polysaccharides bound to carrier; immunogens; monoclonal antibodies; chimeric antibodies; kits; host cells; transgenic plants/animals
05/15/2008US20080112946 Catalytically active recombinant memapsin and methods of use thereof
05/15/2008US20080112943 Biosynthetic Polypeptide Fusion Inhibitors
05/15/2008US20080112938 Transgenic stem cells expressing systemic interference defective-1 (SID-1) for use in gene expression aalysis
05/15/2008US20080112937 Method of Producing Autologous Embryonic Stem Cells
05/15/2008US20080112936 Methods of implanting mesenchymal stem cells for tissue repair and formation
05/15/2008US20080112930 Stent coated with sarcoplasmic reticulum calcium ATPase (SERCA) nucleotide sequences for use in treatment and prevention of vascular constriction
05/15/2008US20080112929 Shielded adenoviral vectors and methods of use
05/15/2008US20080112928 Bacterial Vector
05/15/2008US20080112926 Preparing chimeric polypeptide comprising glycosaminoglycan-binding proteins (GAG) for use in prevention and treatment of skin, nervous system and inflammatory disorders
05/15/2008US20080112916 CHEMICALLY MODIFIED POLYCATION POLYMER FOR siRNA DELIVERY
05/15/2008US20080112915 Skin disorders; metabolic disorders; gene therapy; biocompatability
05/15/2008US20080112887 Pancreatitis
05/15/2008DE102006053059A1 Polypeptid mit Phytaseaktivität und erhöhter Temperaturstabilität der Enzymaktivität sowie dieses codierende Nukleotidsequenz Polypeptide having phytase activity and elevated temperature stability of the enzyme activity, and this encoding nucleotide sequence
05/15/2008CA2703810A1 Method of identifying individuals at risk of thiopurine drug resistance and intolerance
05/15/2008CA2672201A1 Use of myb gene to diagnose and treat t-cell acute lumphoblastic leukemia
05/15/2008CA2669731A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo
05/15/2008CA2669455A1 A set of sequences for targeting expression and control of the post-translational modifications of a recombinant polypeptide
05/15/2008CA2668998A1 Prediction of potential drug-drug interactions using gene expression profiling of drug transporters, cytochrome p450s and nuclear x receptors
05/15/2008CA2668984A1 Methods and devices for the delivery of peptides into the gastric mucosa
05/15/2008CA2668690A1 A recombinant meso-active thermo-stable protein and the process of design and biosynthesis thereof
05/15/2008CA2668417A1 Alphavirus and alphavirus replicon particle formulations and methods
05/15/2008CA2668346A1 Targeting of alpha-1 or alpha-3 subunit of na+, k+-atpase in the treatment of proliferative diseases
05/15/2008CA2666306A1 4-1 bb ligand in inflammatory diseases
05/15/2008CA2664628A1 Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications
05/15/2008CA2658610A1 Methods of increasing secretion of polypeptides having biological activity
05/14/2008EP1921171A1 Method for detecting cytosine methylation in DNA
05/14/2008EP1921169A1 Hybridization probes for nucleic acid detection, universal stems, methods and kits
05/14/2008EP1921157A2 Processes for detecting toxic substances
05/14/2008EP1921153A1 Cell transfection array for use in transfection
05/14/2008EP1921152A1 Transgenic plants with glycine-betaine specific promoter
05/14/2008EP1921151A1 Method for altering the genome of corynebacteria
05/14/2008EP1921150A1 PGRO expression units
05/14/2008EP1921149A1 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
05/14/2008EP1921148A2 Improved enzymes and detergents containing them
05/14/2008EP1921147A2 Improved enzymes and detergents containing them
05/14/2008EP1921146A1 Recombinant vectors based on the modified ankara virus (mav) as preventive and therapeutic vaccines against aids
05/14/2008EP1921145A1 RICE BLAST DISEASE GENE Pi21, RESISTANCE GENE pi21 AND UTILIZATION THEREOF
05/14/2008EP1921144A2 Method for linking sequences of interest
05/14/2008EP1921143A2 Mutants of desoxycytidine kinase having extended enzymatic activity
05/14/2008EP1921142A1 Selection of human monoclonal antibodies by eukaryotic cell display
05/14/2008EP1921141A1 Novel artificial base pair and use thereof
05/14/2008EP1921140A1 Mutant transposon vector and use thereof
05/14/2008EP1921139A1 Novel endoribonuclease
05/14/2008EP1921138A1 Novel endoribonuclease
05/14/2008EP1921137A1 Antibody having inhibitory effect on amyloid fibril formation
05/14/2008EP1921136A1 Nucleic acid for treatment or prevention of immunodeficiency virus infection
05/14/2008EP1921090A1 Genetically modified antibody composition
05/14/2008EP1921089A1 Cytotoxic t-cell epitope peptide and use thereof
05/14/2008EP1921088A2 Peptides and related molecules that bind to tall-1
05/14/2008EP1920783A1 Recombinant RSV virus expression systems and vaccines
05/14/2008EP1920775A1 5'Triphosphate oligonucleotide induces anti-viral response
05/14/2008EP1920061A1 GLP/1/EXENDIN 4 IgG Fc FUSION CONSTRUCTS FOR TREATMENT OF DIABETES
05/14/2008EP1920060A2 Insecticidal compositions and methods for making insect-resistant transgenic plants
05/14/2008EP1920059A2 Antiporter gene from porteresia coarctata for conferring stress tolerance
05/14/2008EP1920058A2 Dehydrin gene from avicennia marina responsible for conferring salt tolerance in plants
05/14/2008EP1920057A1 Polysaccharide synthases
05/14/2008EP1920056A1 Compositions and methods for treating breast cancer
05/14/2008EP1920054A1 Method for separating and purifying rna
05/14/2008EP1920053A2 Subtilases
05/14/2008EP1919958A1 System for screening cells for high expression of a protein of interest (poi)
05/14/2008EP1919953A1 Antibodies directed against a ldl receptor
05/14/2008EP1919949A2 Hla fusion molecules and uses thereof
05/14/2008EP1919946A1 Transglutaminase variants with improved specificity
05/14/2008EP1919943A2 Melanoma-associated mhc class i associated oligopeptides and the uses thereof
05/14/2008EP1919942A2 Methods and compositions for enhancing protein folding
05/14/2008EP1919941A2 Targeting-enhanced activation of galectins
05/14/2008EP1919940A2 Antigenic peptides and their use
05/14/2008EP1919938A1 Modified spider silk proteins
05/14/2008EP1919937A2 Novel restriction endonucleases, dna encoding these endonucleases and methods for identifying new endonucleases with the same or varied specificity
05/14/2008EP1919935A2 Nucleotide sequences encoding insecticidal proteins
05/14/2008EP1919514A2 Polynucleotides encoding isoprenoid modifying enzymes and methods of use thereof
05/14/2008EP1919512A2 Chemically modified oligonucleotides for use in modulating micro rna and uses thereof
1 ... 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 ... 4023